MultiPlan (NYSE:MPLN) Trading Down 6.2% - Here's Why
MultiPlan (NYSE:MPLN) shares fell 6.2% to $67.70, with a trading volume decline of 27% from the average. The company has a market cap of $1.09 billion and a P/E ratio of -0.71. Institutional investors own 87.15% of the stock, with notable increases in stakes from several funds. Analysts currently rate MultiPlan as a Hold, but it is not among the top recommended stocks for investment.
MultiPlan Stock Performance
The firm has a market capitalization of $1.09 billion, a P/E ratio of -0.71 and a beta of 0.13. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 21.73. The business's 50 day simple moving average is $46.72 and its two-hundred day simple moving average is $31.73.
Institutional Trading of MultiPlan
A number of institutional investors and hedge funds have recently bought and sold shares of MPLN. Public Employees Retirement System of Ohio increased its stake in MultiPlan by 75.2% during the 4th quarter. Public Employees Retirement System of Ohio now owns 2,477 shares of the company's stock valued at $37,000 after purchasing an additional 1,063 shares in the last quarter. Northern Trust Corp grew its stake in shares of MultiPlan by 5.5% in the fourth quarter. Northern Trust Corp now owns 14,335 shares of the company's stock worth $212,000 after acquiring an additional 747 shares during the period. XTX Topco Ltd bought a new stake in shares of MultiPlan in the fourth quarter worth approximately $225,000. Jane Street Group LLC grew its stake in shares of MultiPlan by 14.4% in the fourth quarter. Jane Street Group LLC now owns 19,985 shares of the company's stock worth $295,000 after acquiring an additional 2,512 shares during the period. Finally, Walleye Capital LLC bought a new stake in shares of MultiPlan in the fourth quarter worth approximately $359,000. 87.15% of the stock is currently owned by institutional investors.
MultiPlan Company Profile
(Get Free Report)MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Articles
- Five stocks we like better than MultiPlan
- Investing in Commodities: What Are They? How to Invest in Them
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- How to invest in marijuana stocks in 7 steps
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Rocket Lab Stock: Breakout Brewing or Time for Patience?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in MultiPlan Right Now?
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
